Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer: Results from a prospective feasibility study [1]

Katsuyuki Hotta, Akira Inoue, Katsuyuki Kiura, Hiroshi Ueoka, Mitsune Tanimoto, Toshihiro Nukiwa

Research output: Contribution to journal › Article

9 Citations (Scopus)
Original languageEnglish
Pages (from-to)413-415
Number of pages3
JournalLung Cancer
Volume50
Issue number3
DOIs
Publication statusPublished - Dec 2005

Fingerprint

Quinazolines
Cystitis
Gastrointestinal Diseases
Feasibility Studies
Non-Small Cell Lung Carcinoma
Antineoplastic Agents
Vomiting
Lung Neoplasms
Pneumonia
Prospective Studies
gefitinib

ASJC Scopus subject areas

  • Oncology

Cite this

Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer : Results from a prospective feasibility study [1]. / Hotta, Katsuyuki; Inoue, Akira; Kiura, Katsuyuki; Ueoka, Hiroshi; Tanimoto, Mitsune; Nukiwa, Toshihiro.

In: Lung Cancer, Vol. 50, No. 3, 12.2005, p. 413-415.

Research output: Contribution to journal › Article

Hotta, K, Inoue, A, Kiura, K, Ueoka, H, Tanimoto, M & Nukiwa, T 2005, 'Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer: Results from a prospective feasibility study [1]', Lung Cancer, vol. 50, no. 3, pp. 413-415. https://doi.org/10.1016/j.lungcan.2005.07.006
Hotta K, Inoue A, Kiura K, Ueoka H, Tanimoto M, Nukiwa T. Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer: Results from a prospective feasibility study [1]. Lung Cancer. 2005 Dec;50(3):413-415. https://doi.org/10.1016/j.lungcan.2005.07.006
Hotta, Katsuyuki ; Inoue, Akira ; Kiura, Katsuyuki ; Ueoka, Hiroshi ; Tanimoto, Mitsune ; Nukiwa, Toshihiro. / Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer : Results from a prospective feasibility study [1]. In: Lung Cancer. 2005 ; Vol. 50, No. 3. pp. 413-415.
@article{f1639d7b859e49899a1e7baaccc08c3a,
title = "Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer: Results from a prospective feasibility study [1]",
author = "Katsuyuki Hotta and Akira Inoue and Katsuyuki Kiura and Hiroshi Ueoka and Mitsune Tanimoto and Toshihiro Nukiwa",
year = "2005",
month = "12",
doi = "10.1016/j.lungcan.2005.07.006",
language = "English",
volume = "50",
pages = "413--415",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer

T2 - Results from a prospective feasibility study [1]

AU - Hotta, Katsuyuki

AU - Inoue, Akira

AU - Kiura, Katsuyuki

AU - Ueoka, Hiroshi

AU - Tanimoto, Mitsune

AU - Nukiwa, Toshihiro

PY - 2005/12

Y1 - 2005/12

UR - http://www.scopus.com/inward/record.url?scp=33644550293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644550293&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2005.07.006

DO - 10.1016/j.lungcan.2005.07.006

M3 - Article

C2 - 16154232

AN - SCOPUS:33644550293

VL - 50

SP - 413

EP - 415

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

IS - 3

ER -

Access to Document